SATURDAY, FEBRUARY 21

• Keynote Session 4
• Major Symposia 9-10
  • Major Symposium 9: Dendritic Cells in Immune Responses to Cancer
  • Major Symposium 10: T-B Cell Crosstalk in the Tumor Microenvironment and in Immune Response Across Cancers
• Closing Keynote Session

* – Short talk selected from proffered abstracts

Breakfast

7-8 a.m. | Diamond Ballroom 1-3

Keynote Session 4

8-9 a.m. | Diamond Ballroom 5-10

• 8 a.m. | Introduction of Keynote Speaker
  Philip D. Greenberg, Fred Hutchinson Cancer Center, Seattle, Washington
• 8:05 a.m. | Keynote Speaker
  The bomb to a therapy
  Fred Ramsdell, Sonoma Biotherapeutics, Seattle, Washington

Break

9-9:15 a.m. | Diamond Ballroom Foyer

Major Symposia 9-10

9:15-10:45 a.m.

Major Symposium 9: Dendritic Cells in Immune Responses to Cancer

Diamond Ballroom 5-10

Session Chair: Stefani Spranger, Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts

• 9:20 a.m. | Not all anti-tumor immune responses are alike: How dendritic cells shape anti-tumor T cells
  Stefani Spranger
• 9:40 a.m. | Max Krummel, University of California, San Francisco, California
• 10 a.m. | Inflammatory spatial niches distinguished by antigen presentation and interferon response programs explain the high immune response rate of desmoplastic melanoma: Comparison of biopsies from SWOG S1512 and S1616*
  Daniel G. Chen, University of California, Los Angeles, California
• 10:10 a.m. | Leveraging cDC1 populations for enhanced mRNA cancer vaccination*
  Ross Ward, Icahn School of Medicine at Mount Sinai, New York, New York
• 10:20 a.m. | Discussion / Q&A

Major Symposium 10: T-B Cell Crosstalk in the Tumor Microenvironment and in Immune Response Across Cancers

Diamond Ballroom 4

Session Chair: Tina Cascone, The University of Texas MD Anderson Cancer Center, Houston, Texas

• 9:20 a.m. | Investigating T cell immunobiology using genetically engineered models
  Nikhil Joshi, Yale University School of Medicine, New Haven, Connecticut
• 9:40 a.m. | Unleashing the immunotherapeutic potential of B cells inside and outside of tertiary lymphoid structures
  Tullia C. Bruno, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
• 10 a.m. | Characterization and induction of tertiary lymphoid structures in glioma
  Anna Dimberg, Uppsala University, Uppsala, Sweden
• 10:20 a.m. | Discussion / Q&A

Break

10:45-11 a.m. | Diamond Ballroom Foyer

Closing Keynote Session

11-11:45 a.m. | Diamond Ballroom 5-10

• 11 a.m. | Introduction of Keynote Speaker
• 11:05 a.m. | Keynote
  Alexander Marson, University of California, San Francisco, California

Closing remarks

11:45 a.m. | Diamond Ballroom 5-10